home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Insulet Corporation - Common Stock (NQ:PODD)

294.35 +10.84 (+3.82%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Insulet Corporation - Common Stock

< Previous 1 2

...

12 13 14 15 16 17 18 19 Next >

Insulet Announces FDA Clearance of its Omnipod® 5 Automated Insulin Delivery System, First Tubeless System with Smartphone Control

January 28, 2022

From Insulet Corporation

Via Business Wire

If You Invested $100 In This Stock 5 Years Ago, Here's How Much You Would Have Today ↗

January 13, 2022

Insulet (NASDAQ:PODD) has outperformed the market over the past 5 years by 24.86% on an annualized basis. Buying $100 In PODD: 5 years ago, an investor could have purchased 2.30...

Via Benzinga

This Foreboding Sign Looms Over Insulet's Chart ↗

January 13, 2022

If history is any guide, there may be trouble ahead for shares of Insulet (NASDAQ:PODD). A so-called "death cross" has formed on its chart and, not surprisingly, this could be...

Via Benzinga

CORRECTING and REPLACING Insulet to Announce Fourth Quarter and Full Year 2021 Financial Results on February 23, 2022

January 12, 2022

From Insulet Corporation

Via Business Wire

Insulet to Announce Fourth Quarter and Full Year 2021 Financial Results on February 23, 2021

January 12, 2022

From Insulet Corporation

Via Business Wire

Insulet to Present at Nasdaq’s 45th Investor Conference

November 24, 2021

From Insulet Corporation

Via Business Wire

10 Biggest Price Target Changes For Monday ↗

November 08, 2021

Barclays cut Deciphera Pharmaceuticals, Inc. (NASDAQ:

Via Benzinga

10 Biggest Price Target Changes For Friday ↗

November 05, 2021

Wedbush raised Uber Technologies, Inc. (NYSE:UBER)...

Via Benzinga

Insulet Corporation (PODD) Q3 2021 Earnings Call Transcript ↗

November 04, 2021

PODD earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

Insulet Posts Mixed Third Quarter, But Raises Sales Guide On Narrow Beat ↗

November 04, 2021

Insulet raised its full-year sales outlook Thursday on its third-quarter sales beat.

Via Investor's Business Daily

Insulet Reports Third Quarter 2021 Revenue Increase of 18% Year-Over-Year

November 04, 2021

From Insulet Corporation

Via Business Wire

Insulet Honors Diabetes Awareness with Global Activities and Events

November 01, 2021

From Insulet Corporation

Via Business Wire

The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO ↗

November 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &...

Via Benzinga

Insulet Announces Board of Director Changes with Appointment of Luciana Borio, M.D. and Retirement of Sally W. Crawford

October 18, 2021

From Insulet Corporation

Via Business Wire

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline ↗

October 31, 2021

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...

Via Benzinga

Insulet's Insulin Delivery System Shows Durable Glycemic Control With One Year of Use ↗

September 30, 2021

Insulet Corporation (NASDAQ: PODD) presented data from the pivotal trial extension phase of the Omnipod 5 Automated Insulin Delivery System. Omnipod 5 is a...

Via Benzinga

Insulet’s Omnipod® 5 Pivotal Study Extension Data Shows Significant Improvements in Glycemic Control With One Year of Use

September 30, 2021

From Insulet Corporation

Via Business Wire

Insulet to Announce Third Quarter 2021 Financial Results on November 4, 2021

September 29, 2021

From Insulet Corporation

Via Business Wire

5 Top Stocks for September ↗

September 11, 2021

Our analysts give you five picks you can add to your portfolio today.

Via The Motley Fool

The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization ↗

September 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Abbott Laboratories (NYSE:...

Via Benzinga

The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod ↗

September 08, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7) Adial Pharmaceuticals, Inc...

Via Benzinga

Insulet to Present at Upcoming Investor Conferences

August 26, 2021

From Insulet Corporation

Via Business Wire

Looking into Insulet's Return on Capital Employed ↗

August 23, 2021

After pulling data from Benzinga Pro it seems like during Q2, Insulet (NASDAQ:PODD) earned $26.30 million, a 61.35% increase from the preceding quarter. Insulet also posted a...

Via Benzinga

FDA Clears Use Of Eli Lilly's Insulin With Insulet's Infusion Pumps ↗

August 16, 2021

The

Via Benzinga

Insulet Announces FDA Clearance of Lyumjev® Rapid-Acting Insulin for Use with Omnipod® Products in the United States

August 16, 2021

From Insulet Corporation

Via Business Wire

Insulet Introduces Omnipod DASH® System at Australasian Diabetes Congress

August 11, 2021

From Insulet Corporation

Via Business Wire

Insulet Stock Dives On Unexpected Delay For Next-Generation Insulin Pump ↗

August 06, 2021

Insulet said Thursday it expects a one-quarter delay for its next-generation insulin pump, leading PODD stock to tumble on Friday.

Via Investor's Business Daily

Insulet Corporation (PODD) Q2 2021 Earnings Call Transcript ↗

August 06, 2021

PODD earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Insulet Reports Second Quarter 2021 Revenue Increase of 16% Year-Over-Year

August 05, 2021

From Insulet Corporation

Via Business Wire

3 Stocks to Buy That Should Get a Boost From Pandemic-Driven Consumer Weight Gain ↗

July 31, 2021

Athletic-apparel maker Lululemon and two diabetes specialists are poised to get a long-term tailwind from the COVID-19 pandemic.

Via The Motley Fool

< Previous 1 2

...

12 13 14 15 16 17 18 19 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com